Outlook Therapeutics Earnings Report: Q1 Overview

The Q1 earnings report for Outlook Therapeutics (NASDAQ:OTLK) was released on Tuesday, February 17, 2026 at 08:05 AM.

Here's what investors need to know about the latest announcement.

Earnings

Outlook Therapeutics missed estimated earnings by -29.41%, reporting an EPS of $-0.22 versus an estimate of $-0.17.

Revenue was down $1.21 million from the same period last year.

Performance in Previous Earnings

During the previous quarter, the company beat on EPS by $0.05, leading to a 2.9% drop share price change the next day.

To track all earnings releases for Outlook Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.